CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Goldenwell Biotech Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Goldenwell Biotech Inc
581 Boston Mills Road, Suite 300
Phone: (440) 666-7999p:440 666-7999 HUDSON, OH  44236  United States Ticker: GWLLGWLL
Business Summary
Goldenwell Biotech, Inc. is a development-stage nutraceutical company. The Company is primarily engaged in research and development, production and sales of health cares and supplement products. The Company is offering its products under two categories: Polypeptide Freeze-dried Powder and Solid Tablets Products. The Company’s products are JI MAI-Bovine Cardiac Vascular Active Peptide, Double Proline AG- three-dimensional (3D) Active Collagen Peptide, Cartilage Peptide-Type II collagen peptide and Sugar Master. Bovine cardiac vascular active peptide is a protein peptide of vascular homology (amino acid type and its sequence), which is made from healthy and fresh bovine cardiac vascular tissues as raw material. The sugar master product ingredients include natural herbal polypeptides, concentrated and purified natural plant extracts and organic selenium complex. Its Double Proline AG product is designed to be an easily absorbed bioactive collagen.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023YesYes---

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer, Director ShuangLiu 59 8/20/2019 8/20/2019
Treasurer, Director LiYang 52 8/20/2019 8/20/2019
Secretary, Director XieHua 51 8/20/2019 8/20/2019

General Information
Outstanding Shares: 99,000,000 (As of 3/29/2024)
Shareholders: 84
Stock Exchange: OTC
Federal Tax Id: 842896086


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, April 22, 2024